Agoracom: Small Cap Investment - Zenith Epigenetics

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

bionug

Rank: Mail Room [?]

Points: 24 [?]

Votes: 1 Score: 4.0 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

clinical trial

posted on Aug 07, 2021 02:22PM

Another Zen clincial trial listed in ClinicalTrials.gov:

ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer

See presentation by Eric Campeau, slide #16 :

Epigenetic therapeutic target virtual summit 2021

4 Recommendations

Reply New Message

Back To Forum List View

Please to post a reply